Cargando…

Response to Article “Are There Differences in Gut Microbiome in Patients with Type 2 Diabetes Treated by Metformin or Metformin and Insulin?” [Letter]

Detalles Bibliográficos
Autores principales:	Panjaitan, Novaria Sari Dewi, Lestari, Christina Safira Whinie, Maha, Masri Sembiring
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2022
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9760064/ https://www.ncbi.nlm.nih.gov/pubmed/36540346 http://dx.doi.org/10.2147/DMSO.S399410

Ejemplares similares

Thoughtful Response on “MRI-based Texture Analysis for Preoperative Prediction of BRAF V600E Mutation in Papillary Thyroid Carcinoma” [Letter]
por: Panjaitan, Novaria Sari Dewi, et al.
Publicado: (2023)

A Response to Research Article “Cefmetazole Resistance Mechanism for Escherichia Coli Including ESBL-Producing Strains” [Letter]
por: Panjaitan, Novaria Sari Dewi, et al.
Publicado: (2022)

A Response to Article “Distribution of Mcr-1 Harboring Hypervirulent Klebsiella Pneumoniae in Clinical Specimens and Lytic Activity of Bacteriophage KpnM Against Isolates” [Letter]
por: Panjaitan, Novaria Sari Dewi, et al.
Publicado: (2022)

Response to Article “Autophagy Inhibits Inflammation via Down-Regulation of p38 MAPK/mTOR Signaling Cascade in Endothelial Cells” [Letter]
por: Maha, Masri Sembiring, et al.
Publicado: (2023)

The effectiveness of hepatitis B vaccine in toddlers based on the five-year period national basic health research (Riskesdas 2007, 2013 and 2018) in Indonesia
por: Lestari, Christina Safira Whinie, et al.
Publicado: (2023)

Response to Comment to the Article “Are There Differences in Gut Microbiome in Patients with Type 2 Diabetes Treated by Metformin or Metformin and Insulin?” [Response To Letter]
por: Dzięgielewska-Gęsiak, Sylwia, et al.
Publicado: (2022)

Critical Response to Article “Integrated Network Pharmacology and Experimental Validation Approach to Investigate the Mechanisms of Stigmasterol in the Treatment of Rheumatoid Arthritis” [Letter]
por: Rinendyaputri, Ratih, et al.
Publicado: (2023)

A Response to Article Anlotinib Hydrochloride and PD-1 Blockade as a Salvage Second-Line Treatment in Patients with Progress of Local Advanced Non-Small Cell Lung Cancer in Half a Year after Standard Treatment [Letter]
por: Panjaitan, Novaria Sari Dewi
Publicado: (2022)

Thoughtful Discussion on Article “Antimicrobial Peptide Cec4 Eradicates Multidrug-Resistant Acinetobacter baumannii in vitro and in vivo” [Letter]
por: Hidayat, Syarif, et al.
Publicado: (2023)

A Response to Article “Anti-Diarrheal Activity of Hydromethanolic Crude Extract and Solvent Fractions of Acacia Seyal (Fabaceae) Roots in Mice” [Letter]
por: Panjaitan, Novaria Sari Dewi, et al.
Publicado: (2022)

Response on Article “A Sustained-Release Nanosystem with MRSA Biofilm-Dispersing and -Eradicating Abilities Accelerates Diabetic Ulcer Healing” [Letter]
por: Panjaitan, Novaria Sari Dewi, et al.
Publicado: (2023)

Response to Article “Serum Levels of Galectin-9 are Increased in Cervical Cancer Patients and are Higher in Advanced Clinical Stages” [Letter]
por: Panjaitan, Novaria Sari Dewi, et al.
Publicado: (2022)

Are There Differences in Gut Microbiome in Patients with Type 2 Diabetes Treated by Metformin or Metformin and Insulin?
por: Dzięgielewska-Gęsiak, Sylwia, et al.
Publicado: (2022)

Critical Response: “Does the Mutation of Cancer Driver Genes IDH1/2 and CD204 Influence Cancer Metabolism and Tumor Associated Macrophage Recruitment in Tumor Microenvironment” [Letter]
por: Panjaitan, Novaria Sari Dewi, et al.
Publicado: (2023)

Questions Regarding Variants in ADIPOQ in Maternal Circulating Adipokine Profile in Gestational Diabetes Mellitus [Letter]
por: Panjaitan, Novaria Sari Dewi, et al.
Publicado: (2023)

Serum Levels of Tumor Necrosis Factor-α and Vascular Endothelial Growth Factor in the Subtypes of Clinical High Risk Individuals: A Prospective Cohort Study [Letter]
por: Lienggonegoro, Lisa Andriani, et al.
Publicado: (2023)

A Response to Article “Selenium-Modified Chitosan Induces HepG2 Cell Apoptosis and Differential Protein Analysis” [Letter]
por: Mariya, Sela S, et al.
Publicado: (2023)

Gut microbiome differences between metformin‐ and liraglutide‐treated T2DM subjects
por: Wang, Zhang, et al.
Publicado: (2017)

Metformin modulates the gut microbiome in broiler breeder hens
por: Van Syoc, Emily, et al.
Publicado: (2022)

Association of metformin administration with gut microbiome dysbiosis in healthy volunteers
por: Elbere, Ilze, et al.
Publicado: (2018)

The Relationship between the Gut Microbiome and Metformin as a Key for Treating Type 2 Diabetes Mellitus
por: Lee, Chae Bin, et al.
Publicado: (2021)

Metformin-induced reductions in tumor growth involves modulation of the gut microbiome()
por: Broadfield, Lindsay A., et al.
Publicado: (2022)

Effects of Metformin, Metformin Plus Rosiglitazone, and Metformin Plus Lifestyle on Insulin Sensitivity and β-Cell Function in TODAY
Publicado: (2013)

Microalbuminuria in Hyperglycemic Critically Ill Patients Treated with Insulin or Metformin
por: Panahi, Yunes, et al.
Publicado: (2011)

EtcABC, a Putative EII Complex, Regulates Type 3 Fimbriae via CRP-cAMP Signaling in Klebsiella pneumoniae
por: Panjaitan, Novaria Sari Dewi, et al.
Publicado: (2019)

Extended spectrum beta lactamase (ESBL)-producing Escherichia coli and Klebsiella pneumoniae in Indonesia and South East Asian countries: GLASS Data 2018
por: Sunarno, Sunarno, et al.
Publicado: (2023)

Metformin and Cancer Occurrence in Insulin-Treated Type 2 Diabetic Patients
por: Monami, Matteo, et al.
Publicado: (2011)

Metformin Improves Cognition by Reducing Leaky Gut and Benefiting Gut Microbiome–Goblet Cell–Mucin Axis
por: Yadav, Hariom, et al.
Publicado: (2020)

Effects of vancomycin‐induced gut microbiome alteration on the pharmacodynamics of metformin in healthy male subjects
por: Kim, Eunwoo, et al.
Publicado: (2021)

Mechanisms of metformin action: In and out of the gut
por: Minamii, Takahiro, et al.
Publicado: (2018)

Metformin acts in the gut and induces gut-liver crosstalk
por: Tobar, Natália, et al.
Publicado: (2023)

Metformin and Malignant Tumors: Not Over the Hill [Response to Letter]
por: Leng, Weiling, et al.
Publicado: (2021)

The PTS Components in Klebsiella pneumoniae Affect Bacterial Capsular Polysaccharide Production and Macrophage Phagocytosis Resistance
por: Panjaitan, Novaria Sari Dewi, et al.
Publicado: (2021)

Role of gut microbiome in regulating the effectiveness of metformin in reducing colorectal cancer in type 2 diabetes
por: Huang, Qi-You, et al.
Publicado: (2020)

Metabolic modelling of the human gut microbiome in type 2 diabetes patients in response to metformin treatment
por: Ezzamouri, Bouchra, et al.
Publicado: (2023)

The role of EII complex in the bacterial responses to the glucose-survey in clinical Klebsiella pneumoniae isolates
por: Horng, Yu-Tze, et al.
Publicado: (2023)

Retrospective Evaluation of Metformin and/or Metformin Plus a New Polysaccharide Complex in Treating Severe Hyperinsulinism and Insulin Resistance in Obese Children and Adolescents with Metabolic Syndrome
por: Stagi, Stefano, et al.
Publicado: (2017)

RECURRENT IMPETIGO HERPETIFORMIS WITH DIABETES AND HYPOALBUMINEMIA SUCCESSFULLY TREATED WITH CYCLOSPORINE, ALBUMIN, INSULIN AND METFORMIN
por: Lakshmi, Chembolli, et al.
Publicado: (2010)

Beneficial effects of combined resveratrol and metformin therapy in treating diet‐induced insulin resistance
por: Frendo‐Cumbo, Scott, et al.
Publicado: (2016)

Feto-maternal outcomes and Glycemic control in Metformin versus insulin treated Gestational Diabetics
por: Arshad, Rabia, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_b5qd65o4bvt13kdgcimcfg7c3h